UK renal transplantation · NHSBT-commissioned
Kidney transplantation in the UK — living and deceased donor pathways.
The best treatment for end-stage kidney disease — better quality of life and better survival than dialysis. Twenty-three NHS adult transplant centres, one national waiting list, and the option of a living donor when a family member or friend is able to give.
Why patients trust us
- 01
A specialist transplant team, not a generalist
Kidney transplantation is done inside one of 23 NHS-commissioned adult centres in the UK — with a full MDT of transplant nephrologists, surgeons and immunologists. We help you understand the pathway, not sell it to you.
- 02
Living and deceased donation, honestly compared
A living-donor kidney lasts longer and works faster than a deceased-donor kidney. We say so plainly, and walk you through what donation actually involves for a family member or friend.
- 03
Independent, and free
Kidney transplantation itself is NHS-funded via NHS Blood and Transplant. Our guidance is impartial and costs you nothing.
Pathway and indicative costs
What a UK kidney transplant actually costs.
The transplant itself is NHS-funded via NHS Blood and Transplant. Private costs sit in the pre-transplant workup — the workup that decides whether you are listed at all.
In short
Transplantation itself is NHS-funded; a private pre-transplant workup runs about £2,000–£4,000.
| Step | Indicative cost | Typical duration | Turnaround |
|---|---|---|---|
| Kidney transplant (NHS-funded) | NHS-funded | 3–4 h theatre | 5–10 day admission |
| Living-donor nephrectomy (NHS-funded) | NHS-funded | 2–3 h theatre | 3–5 day admission |
| Pre-transplant nephrology opinion (private) | £300–£500 | 45–60 min | Report same week |
| Private CT renal angiogram | £700–£1,200 | 30 min | Report 48 h |
| Private cardiology workup (echo + stress) | £800–£1,500 | Half-day | Report 48 h |
| HLA / PRA antibody testing (private lab) | £400–£800 | Blood draw | Report 1–2 weeks |
Costs vary by clinic and by which parts of the workup your NHS team wants repeated privately for speed. We come back with a firm quote and a plan within one working day.
The problem
The right centre, the right timing, the right donor.
The three biggest levers on outcomes are being referred early enough, being listed at the right centre, and knowing whether a living donor is realistic for you. We help you get all three right.
-
Referred too late?
Referral at eGFR ~20 gives the best shot at pre-emptive transplantation — starting dialysis first worsens outcomes.
-
Unsure about a donor?
A family member, spouse or friend may be a candidate. We explain what living donation actually involves before anyone commits.
-
Complex immunology?
ABO- or HLA-incompatible pairs still have routes to transplant — via the UK Living Kidney Sharing Scheme or specialist desensitisation.
The journey
From referral to a working transplant — what happens, in order.
A concierge that stays with you from first nephrology referral through listing, admission and lifelong follow-up.
Phase 1 · Before transplant
Referral, workup, listing
Phase 2 · Admission
Theatre, HDU and ward
Phase 3 · After
Lifelong follow-up
- 01
Before
You tell us where you are
A short, confidential form. eGFR trend, cause of kidney disease, whether dialysis has started, and whether a potential living donor is in the picture.
- 02
Before
We come back with the pathway
Within one working day: which UK transplant centre suits you, referral timing (usually at eGFR around 20), and how living donation fits alongside listing for a deceased-donor kidney.
- 03
Before
Assessment and listing
Full MDT workup — cardiac, CT angiogram, dental, malignancy screen, virology, tissue typing and HLA antibodies. Listing on the NHSBT national waiting list once cleared.
- 04
Admission
The call, or the planned date
For a deceased-donor kidney, a call at short notice and admission the same day. For a living donor, a planned admission alongside your donor.
- 05
Admission
The transplant itself
Three to four hours in theatre under GA. The new kidney is placed in the iliac fossa; the vessels are joined to the iliac artery and vein and the ureter to the bladder.
- 06
Admission
HDU and ward
Twenty-four to forty-eight hours in HDU, then five to ten days on the transplant ward while urine output, creatinine and tacrolimus levels settle.
- 07
After
Life on immunosuppression
Weekly clinic for a month, then monthly, then every three to six months. Lifelong tacrolimus, MMF and low-dose steroid — with skin, cardiac and infection surveillance built in.
Typical pathway: referral at eGFR ~20, listing once workup complete. Median wait for a deceased-donor kidney: 2–3 years; a planned living-donor transplant can proceed as soon as both parties are cleared.
When it helps
When kidney transplantation is the right step.
The situations that most commonly lead to referral — plus the red flag that means calling the transplant centre, not the GP.
-
CKD stage 4–5 approaching dialysis
An eGFR falling toward 20 is the point to refer — pre-emptive transplantation (before dialysis) gives the best outcomes.
-
On dialysis already
Haemodialysis or peritoneal dialysis with life expectancy that would clearly benefit from a transplant — most working-age adults qualify.
-
Diabetic nephropathy
The single commonest cause of ESKD in the UK. Combined kidney–pancreas transplantation is considered for selected type 1 diabetes patients.
-
Polycystic kidney disease
ADPKD is a leading indication — with a slow, predictable decline that lets us plan living donation and listing well in advance.
-
Glomerulonephritis and IgA nephropathy
Immune-mediated kidney disease that has progressed to ESKD — with a small recurrence risk in the graft that the transplant team monitors.
-
Willing living donor available
A family member, spouse or friend who wants to be assessed — the fastest route to a transplant, with the best long-term outcomes.
-
Immunologically incompatible pair
ABO- or HLA-incompatible donor–recipient pairs can enter the UK Living Kidney Sharing Scheme (paired/pooled exchange) or specialist desensitisation.
-
Red flag: hyperacute rejection or graft thrombosis
Sudden anuria, graft pain or fever in the first days after transplant is an emergency — call the transplant centre, not the GP.
Donor options
Not every kidney transplant is the same.
The donor type, the immunological match and the timing all shape long-term outcomes. Here is what each option actually involves.
-
Deceased-donor (DBD) transplant
Kidney from a donor after brain-stem death. Allocated via the NHSBT national kidney offering scheme (2019 update), which prioritises HLA-match, age and hard-to-match recipients.
-
Deceased-donor (DCD) transplant
Kidney from a donor after circulatory death. Longer cold-ischaemia risk and higher rate of delayed graft function — but overall long-term outcomes now comparable to DBD.
-
Directed living donation
A family member, spouse or friend donates directly to you. HTA-approved, planned, and gives the best graft survival of any option.
-
Non-directed altruistic donation
A stranger donates one kidney to the national pool — often triggering a chain of transplants. HTA-approved and rigorously assessed.
-
Paired / pooled donation (UKLKSS)
For an ABO- or HLA-incompatible pair — the UK Living Kidney Sharing Scheme runs quarterly matching runs to swap donors between pairs across the country.
-
ABO-incompatible transplantation
Cross-blood-group transplantation using immunoadsorption or plasma exchange to remove anti-A/B antibodies before surgery — now routine at specialist centres.
-
HLA-incompatible transplantation
For highly sensitised recipients with donor-specific antibodies. Complex desensitisation at specialist centres — reserved for when no better option exists.
-
Combined kidney–pancreas transplant
For selected type 1 diabetes patients with ESKD — restores insulin independence alongside kidney function. Small number of UK centres.
Our UK transplant network
NHS-commissioned centres, picked with care.
Twenty-three adult transplant centres cover the UK. We match you to the one that suits your immunology, your geography, and — if you have one — your living donor.
Selection criteria
How we choose the right transplant centre for you.
-
Transplantation performed inside NHSBT-commissioned adult transplant centres (23 in the UK)
-
Full multidisciplinary team — nephrologist, surgeon, immunologist, cardiologist, psychologist, specialist nurse
-
Living-donor pathway HTA-approved and independently assessed
-
Access to paired / pooled donation, ABO- and HLA-incompatible programmes
Safety and life after transplant
What to expect afterwards — honestly.
A working transplant is the best treatment for end-stage kidney disease, but it is a trade: a shorter admission and better daily life in exchange for lifelong immunosuppression and long-term surveillance.
-
Delayed graft function is common
Around 30% of deceased-donor kidneys need short-term dialysis in the first days; under 5% of living-donor kidneys do. It usually resolves within a fortnight.
-
Rejection — acute and antibody-mediated
Acute cellular rejection is treated with steroid pulses; antibody-mediated rejection needs plasma exchange, IVIG and sometimes rituximab. Both are picked up on protocol biopsy and blood tests.
-
Immunosuppression, for life
Induction with basiliximab or ATG at surgery; maintenance with tacrolimus, mycophenolate mofetil and prednisolone. Tacrolimus trough is monitored to a target of roughly 5–10 ng/mL long-term.
-
Infection risk is real
PJP prophylaxis (co-trimoxazole) for six months; CMV prophylaxis (valganciclovir) for three to six months in high-risk pairs; ongoing BK virus and CMV PCR surveillance.
-
Skin cancer surveillance annually
Long-term immunosuppression sharply raises the risk of squamous- and basal-cell skin cancers. Annual dermatology review, sun protection, and low threshold for lesion referral.
-
Cardiovascular risk is the biggest killer
Statin, BP target under 130/80, HbA1c control, and stopping smoking do more for long-term survival after transplant than any single drug change.
-
Vaccinations — no live vaccines
Inactivated vaccines (flu, COVID, pneumococcal) are encouraged; live vaccines (MMR, yellow fever, live shingles) are avoided lifelong after transplant.
-
Fertility can return
Fertility often returns within months of a working transplant — contraception advice matters, and pregnancy is planned at twelve to twenty-four months post-transplant under specialist care.
-
Red flags
Sudden drop in urine output, graft-site pain, fever, or a sharp creatinine rise on home monitoring — call the transplant centre the same day, not the GP.
Reading your transplant note
Your transplant note in four parts. Read the last one first.
Whichever centre performs the transplant, the discharge note tends to keep to the same shape.
A quiet reminder
Transplant language is precise and can read coldly — we translate it for you.
If you would like us to talk you through the note before your next clinic, just ask.
- 01 Header
Donor type, HLA-match and cold-ischaemia time
Whether the kidney was from a living or deceased donor (DBD/DCD), the HLA mismatch, and — for deceased donors — how many hours the kidney spent on ice.
- 02 Technique
Operative note and anastomoses
Iliac fossa side used, arterial and venous anastomoses, ureteric implantation technique (extravesical or Politano–Leadbetter), and induction agent given.
- 03 Findings
Early graft function and complications
Urine output on table, initial creatinine trajectory, any delayed graft function or need for dialysis, and any early surgical issues (bleeding, ureteric leak, lymphocele).
- 04 Impression
Immunosuppression plan and follow-up
Read this first: tacrolimus target, PJP and CMV prophylaxis, next clinic date, and the plan for skin, cardiac and viral surveillance.
Recognised by major UK insurers
Kidney transplantation itself is NHS-funded via NHS Blood and Transplant and is not routinely covered by private insurance. Insurers may fund the pre-transplant workup — cardiology, imaging and specialist opinions — where medically indicated. We confirm cover before booking.
Frequently asked
Everything we get asked about kidney transplantation.
Quick answers on waiting times, living versus deceased donation, life after transplant, and long-term outcomes.
-
Is a kidney transplant better than dialysis?
For most working-age adults, yes. A functioning transplant restores near-normal kidney function, improves quality of life, and — on matched comparisons — extends life by around ten years versus staying on dialysis. It is the preferred treatment for end-stage kidney disease when medically suitable.
-
Living donor or deceased donor — which is better?
A living-donor kidney has better outcomes on every measure: it starts working faster, lasts longer (median >20 years vs ~15 years), and has a lower rate of delayed graft function. If a family member or friend is willing to be assessed, that is almost always the best option.
-
How long is the wait for a deceased-donor kidney in the UK?
The NHSBT active waiting list is around 5,000 people. Median wait is two to three years, with blood group O usually waiting longest and people from ethnic minorities disproportionately affected by donor-pool composition. Paediatric patients are prioritised by the allocation algorithm.
-
When should I be referred for a transplant assessment?
At an eGFR of around 20 — approaching but not yet on dialysis. Pre-emptive listing (with an eGFR target near 15 to actually receive the transplant) gives the best long-term outcomes and avoids the harms of extended dialysis.
-
What is the UK Living Kidney Sharing Scheme?
The UKLKSS is a quarterly matching run that pairs immunologically incompatible donor–recipient pairs across the country, so each recipient gets a compatible kidney from another pair’s donor. It has transformed access to living donation for people with ABO- or HLA-incompatible partners.
-
What are the main long-term complications?
Chronic allograft vasculopathy (the main cause of late graft loss), diabetes and hypertension from immunosuppression, skin cancer from accumulated immunosuppression, post-transplant lymphoproliferative disease (EBV-driven), and cardiovascular disease — which remains the biggest cause of death with a working graft.
-
How long does a transplanted kidney last?
One-year graft survival is around 95% for deceased-donor and 98% for living-donor kidneys. At five years it is 85–90% (>90% for living donors); at ten years around 75% (>85% for living donors). Median graft survival is roughly 15 years — over 20 years for a living-donor kidney.
-
Is a private kidney transplant possible in the UK?
Not really. Kidney transplantation is commissioned nationally by NHS Blood and Transplant and delivered through 23 NHS adult transplant centres. Some private centres coordinate the pre-transplant workup — cardiology, imaging, HLA testing — but the transplant itself is NHS.
Related treatments
Looking for something else?
Nearby in the library